WELLNEO SUGAR Co., Ltd. (TYO:2117)
Japan · Delayed Price · Currency is JPY 2,336.00
+29.00 (1.26%)
Aug 1, 2025, 3:30 PM JST
Blueprint Medicines Revenue
In the fiscal year ending March 31, 2025, WELLNEO SUGAR had annual revenue of 97.07B JPY with 5.29% growth. WELLNEO SUGAR had revenue of 22.24B in the quarter ending March 31, 2025, with 0.13% growth.
Revenue
97.07B
Revenue Growth
+5.29%
P/S Ratio
0.79
Revenue / Employee
131.35M
Employees
739
Market Cap
76.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 97.07B | 4.88B | 5.29% |
| Mar 31, 2024 | 92.19B | 33.85B | 58.01% |
| Mar 31, 2023 | 58.35B | 12.29B | 26.67% |
| Mar 31, 2022 | 46.06B | 2.30B | 5.24% |
| Mar 31, 2021 | 43.77B | -4.04B | -8.45% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Japan Tobacco | 3,236.41B |
| Seven & i Holdings | 10.37T |
| Ajinomoto Co. | 1,530.56B |
| Kao Corporation | 1,652.51B |
| Pan Pacific International Holdings | 2,215.91B |
| Asahi Group Holdings | 2,953.23B |
| Unicharm | 980.22B |
| Kirin Holdings Company | 2,382.48B |